115. 遺伝性周期性四肢麻痺 Disease details / Clinical trials / Drug dev / DR info

臨床試験数 : 11 / 薬物数 : 20 - (DrugBank : 7) / 標的遺伝子数 : 20 - 標的パスウェイ数 : 13

薬物、開発者（Primary Sponsor）、臨床試験情報（症例登録開始年（Enrollment year）、フェーズ、ID、実施国）
4,5-dichloro-1,3-benzenedisulphonamide
   University of Rochester
      2010   Phase 3   EUCTR2008-002306-19-GB   United Kingdom
Acetazolamide
   University of Rochester
      2008   Phase 1   NCT00839501   United Kingdom;United States
Bumetanide
   University College of London
      2014   Phase 2   EUCTR2013-004195-36-GB   United Kingdom
   University College, London
      2015   Phase 2   NCT02582476   United Kingdom
DCP
   University of Rochester
      2010   Phase 3   EUCTR2008-002306-19-GB   United Kingdom
Dichlorphenamide
   National Center for Research Resources (NCRR)
      1992   Phase 3   NCT00004802   -
   University of Rochester
      2010   Phase 3   EUCTR2008-002306-19-GB   United Kingdom
      2007   Phase 3   NCT00494507   Canada;France;Italy;United Kingdom;United States
Flecainide + BETA-blocker
   Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
      2025   Phase 2   NCT06205550   -
Idebenone
   Xuanwu Hospital, Capital University of Medical Sciences
      2017   Phase 4   ChiCTR-IPR-17010316   China
Lamotrigin actavis
   Grete Andersen
      2013   -   EUCTR2013-003309-24-DK   Denmark
Lamotrigin ”nordic prime 100 MG
   Rigshospitalet, department of Neurology
      2022   Phase 3   EUCTR2021-003784-94-DK   Denmark
Lamotrigin ”nordic prime 25 MG
   Rigshospitalet, department of Neurology
      2022   Phase 3   EUCTR2021-003784-94-DK   Denmark
Lamotrigin ”nordic prime 50 MG
   Rigshospitalet, department of Neurology
      2022   Phase 3   EUCTR2021-003784-94-DK   Denmark
Lamotrigine
   Grete Andersen
      2013   -   EUCTR2013-003309-24-DK   Denmark
   Grete Andersen, MD
      2013   Phase 3   NCT01939561   Denmark
   Rigshospitalet, department of Neurology
      2022   Phase 3   EUCTR2021-003784-94-DK   Denmark
Mexiletine
   Rigshospitalet, department of Neurology
      2022   Phase 3   EUCTR2021-003784-94-DK   Denmark
Namuscla
   Rigshospitalet, department of Neurology
      2022   Phase 3   EUCTR2021-003784-94-DK   Denmark
Potassium
   University of Rochester
      2008   Phase 1   NCT00839501   United Kingdom;United States